|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/4523 | (2006.01) | ||
| A61K 31/18 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4523 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3618875 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18726224.1 |
| Date of filing the European patent application | 2018-04-30 | |
| (97) | Date of publication of the European application | 2020-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/052989 |
| Date | 2018-04-30 |
| (87) | Number | WO 2018/203219 |
| Date | 2018-11-08 |
| (30) | Number | Date | Country code |
| 201762500108 P | 2017-05-02 | US | |
| 201862656423 P | 2018-04-12 | US |
| (72) |
COOKE, Vesselina , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION THERAPY COMPRISING A RAF INHIBITOR AND TRAMETINIB |
| COMBINATION THERAPY COMPRISING A RAF INHIBITOR AND TRAMETINIB |